Endothelial nitric oxide synthase gene variants contribute to oxidative stress in COPD

Biochemical and Biophysical Research Communications

Volumn 361, Issue 1, 2007, Pages 182-188

  Arif, Ehtesham ^a,c   Ahsan, Aarif ^a   Vibhuti, Arpana ^a   Rajput, Charu ^a   Deepak, Desh ^b   Athar, Mohammad ^c   Singh, Bhawani ^b   Pasha, M A Qadar ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Chronic obstructive pulmonary disease; eNOS; Malonaldehyde; Nitrite; Polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MALONALDEHYDE; NITRITE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MALE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 34547117626     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.008     Document Type: Article

References (36)

1. Hurd S.S. International efforts directed at attacking the problem of COPD. Chest 117 (2000) 336S-338S
2. Snider G. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Annu. Rev. Med. 40 (1989) 411-429
3. Barnes P.J. Chronic obstructive pulmonary disease. N. Engl. J. Med. 343 (2000) 269-280
4. Cohen B.H., Diamond E.L., Graves C.G., Kreiss K., Levy D.A., Menkes H.A., Permutt S., Quaskey S., and Tockman M.S. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 2 (1977) 523-526
5. Ahsan A., Ram R., Baig M.A., and Qadar Pasha M.A. ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease. Clin. Biochem. 37 (2004) 1037-1040
6. Sandford A.J., and Silverman E.K. Chronic obstructive pulmonary disease. 1: susceptibility factors for COPD the genotype-environment interaction. Thorax 57 (2002) 736-741
7. Arif E., Vibhuti A., Alam P., Deepak D., Singh B., Athar M., and Qadar Pasha M.A. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease. Clin. Chem. Acta. 382 (2007) 37-42
8. Peinado V.I., Barbera J.A., Ramirez J., Gomez F.P., Roca J., Jover L., Gimferrer J.M., and Rodriguez-Roisin R. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. Physiol. 274 (1998) L908-L913
9. Arnal J.F., Dinh-Xuan A.T., Pueyo M., Darblade B., and Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol. Life Sci. 55 (1996) 1078-1087
10. MacNee W., and Rahman I. Oxidants and antioxidants as therapeutic targets in COPD. Am. J. Respir. Crit. Care. Med. 160 (1999) S58-S65
11. Sanguinetti C.M. Oxidant/antioxidant imbalance: role in the pathogenesis of COPD. Respiration 59 (1992) 20-23
12. Deykin A., Massaro A.F., Drazen J.M., and Israel E. Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am. J. Respir. Crit. Care. Med. 165 (2002) 1597-1601
13. Adamkiewicz G., Ebelt S., Syring M., Slater J., Speizer F.E., Schwartz J., Suh H., and Gold D.R. Association between air pollution exposure and exhaled nitric oxide in an elderly population. Thorax 59 (2004) 204-209
14. Corradi M., Montuschi P., Donnelly L.E., Pesci A., Kharitonov S.A., and Barnes P.J. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am. J. Respir. Crit. Care. Med. 163 (2001) 854-858
15. Miyamoto Y., Saito Y., Nakayama M., Shimasaki Y., Yoshimura T., Yoshimura M., Harada M., Kajiyama N., Kishimoto I., Kuwahara K., Hino J., Ogawa E., Hamanaka I., Kamitani S., Takahashi N., Kawakami R., Kangawa K., Yasue H., and Nakao K. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T/C mutation associated with coronary spastic angina. Hum. Mol. Genet. 9 (2000) 2629-2637
16. Forstermann U., and Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113 (2006) 1708-1714
17. Kinnula V.L. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 60 (2005) 693-700
18. Cantin A., and Crystal R.G. Oxidants, antioxidants and the pathogenesis of emphysema. Eur. J. Respir. Dis. 66 (1985) 7-17
19. Yildiz P., Oflaz H., Cine N., Erginel-Unaltuna N., Erzengin F., and Yilmaz V. Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD. Respir. Med. 97 (2003) 1282-1288
20. Ahsan A., Norboo T., Baig M.A., and Qadar Pasha M.A. Simultaneous selection of wild-type genotypes of G894T and 4B/4A polymorphisms of NOS3 gene associates with HA adaptation. Ann. Hum. Genet. 69 (2005) 260-267
21. Hibi K., Ishigami T., Tamura K., Mizushima S., Nyui N., Fujita T., Ochiai H., Kosuge M., Watanabe Y., Yoshii Y., Kihara M., Kimura K., Ishii M., and Umemura S. Endothelial nitric oxide gene polymorphism and acute myocardial infarction. Hypertension 32 (1998) 521-526
22. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miyamoto Y., and Nakao K. 786T/C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
23. Storm van's Gravesande K., Wechsler M.E., Grasemann H., Silverman E.S., Le L., Palmer L.J., and Drazen J.M. Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am. J. Respir. Crit. Care. Med. 168 (2003) 228-231
24. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., and Wilcken D.E. A smoking dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2 (1996) 41-45
25. American Thoracic Society. Standardization of Spirometry. Am. Rev. Respir. Dis.136 (1987) 1285-298.
26. 15 N] nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
27. Wright J.R., Colby H.D., and Miles P.R. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys. 206 (1981) 296-304
28. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nuc. Acids. Res. 16 (1988) 1215
29. Schulz R., Rassaf T., Massion P.B., Kelm M., and Balligand J.L. Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacol. Ther. 108 (2005) 225-256
30. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., Kawaguchi Y., Hosoya T., and Igari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245 (1998) 190-193
31. Veldman B.A., Spiering W., Doevendans P.A., Vervoort G., Kroon A.A., de Leeuw P.W., and Smits P. The Glu298Asp polymorphism of the NOS3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens. 20 (2002) 2023-2027
32. Yoon Y., Song J., Hong S.H., and Kim J.Q. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 46 (2000) 1626-1630
33. Ansarin K., Chatkin J.M., Ferreira I.M., Gutierrez C.A., Zamel N., and Chapman K.R. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur. Respir. J. 17 (2001) 934-938
34. Connelly L., Jacobs A.T., Palacios-Callender M., Moncada S., and Hobbs A.J. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J. Biol. Chem. 278 (2003) 26480-26487
35. Cook S., Vollenweider P., Menard B., Egli M., Nicod P., and Scherrer U. Increased eNOS and pulmonary iNOS expression in eNOS null mice. Eur. Respir. J. 21 (2003) 770-773
36. Xie Y.M., and Wolin M.S. Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia/reoxygenation. Circulation 94 (1996) 2580-2586